Frontiers in Drug Discovery

Published by Frontiers Media S.A.

Open access · CC BY · In DOAJ · Switzerland · Computational Drug Discovery Methods

Journal at a glance

ISSN

2674-0338

Publisher

Frontiers Media S.A.

Country

Switzerland

Language

en

License

CC BY

Also known as: Front Drug Discov (Lausanne) (Abbreviation)

Indexing

• Scopus: Indexed
• DOAJ: Active

Metrics

Subjects

• Computational Drug Discovery Methods
• SARS-CoV-2 and COVID-19 Research
• vaccines and immunoinformatics approaches
• Monoclonal and Polyclonal Antibodies Research
• Microbial Natural Products and Biosynthesis
• COVID-19 Clinical Research Studies
• Machine Learning in Materials Science
• Medicine: Therapeutics. Pharmacology
• Therapeutics and pharmacology

Articles on PubPorta

The most recent records PubPorta holds for this journal.

• Redefining the geography of pharmaceutical innovation: Kelly Chibale as a harbinger for integrated drug discovery in Africa (2026)
• Minireview Kefir as a source of antimicrobial compounds against bacterial pathogens (2026)
• Toward explainable and adaptive artificial intelligence systems for antimicrobial peptide discovery under resistance pressure (2026)
• Modulating the human gut microbiome-host system: a new drug discovery paradigm (2026)
• Fundamentals of dermatologic drug discovery (2026)

Similar journals

• Biomedical and Biotechnology Research Journal — India · Open access · Same subject: COVID-19 Clinical Research Studies, Same subject: Computational Drug Discovery Methods, 3 shared subjects in total
• Medicine in Drug Discovery — Kingdom of the Netherlands · Open access · Same subject: COVID-19 Clinical Research Studies, Same subject: Computational Drug Discovery Methods, 3 shared subjects in total
• Avicenna Journal of Medical Biotechnology — Iran · — · Same subject: Monoclonal and Polyclonal Antibodies Research, Same subject: SARS-CoV-2 and COVID-19 Research, 3 shared subjects in total
• hLife — Open access · Same subject: COVID-19 Clinical Research Studies, Same subject: SARS-CoV-2 and COVID-19 Research, 3 shared subjects in total
• COVID — Switzerland · Open access · Same subject: COVID-19 Clinical Research Studies, Same subject: SARS-CoV-2 and COVID-19 Research, Same country, Same language
• Immuno — Switzerland · Open access · Same subject: COVID-19 Clinical Research Studies, Same subject: SARS-CoV-2 and COVID-19 Research, Same country, Same language

Sources: DOAJ, OpenAlex, NLM Catalog, Crossref, Scopus · Last verified 2026-09-05

Author guidelines